img

Global Animal Flu Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Animal Flu Vaccine Market Insights, Forecast to 2034

Global Animal Flu Vaccine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Animal Flu Vaccine industry is evaluated to reach US$ million in 2034. The CAGR will be % during 2024 to 2034.
Globally, Animal Flu Vaccine key manufacturers include Zoetis US, Merck Animal Health, Gamma Vaccines Pty Ltd, Ceva Animal Health, Boehringher Ingelheim and Novartis China, etc. Zoetis US, Merck Animal Health, Gamma Vaccines Pty Ltd are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Animal Flu Vaccine were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Animal Flu Vaccine market and estimated to attract more attentions from industry insiders and investors.
Animal Flu Vaccine can be divided into Monovalent, Bivalent and Others,, etc. Monovalent is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2034.
Animal Flu Vaccine is widely used in various fields, such as Birds, Dog, Pig and Others, etc. Birds provides greatest supports to the Animal Flu Vaccine industry development. In 2022, global % sales of Animal Flu Vaccine went into Birds filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Animal Flu Vaccine market from 2024 to 2034, aiming to help readers to get a comprehensive understanding of global Animal Flu Vaccine market with multiple angles. Items like regional sales, revenue from 2024 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2024 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2024 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Zoetis US
Merck Animal Health
Gamma Vaccines Pty Ltd
Ceva Animal Health
Boehringher Ingelheim
Novartis China
Segment by Type
Monovalent
Bivalent
Others

Segment by Application


Birds
Dog
Pig
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2024 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Animal Flu Vaccine plant distribution, commercial date of Animal Flu Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2024 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2024 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2024 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2024 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2024 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2024 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2024 to 2034 in China. Product sales and revenue analysis of China from 2024 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2024 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2024 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2024 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2024 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Animal Flu Vaccine introduction, etc. Animal Flu Vaccine Sales, Revenue, Price and Gross Margin of each company from 2024 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Animal Flu Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Animal Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Animal Flu Vaccine Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 Monovalent
1.2.3 Bivalent
1.2.4 Others
1.3 Market by Application
1.3.1 Global Animal Flu Vaccine Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Birds
1.3.3 Dog
1.3.4 Pig
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Animal Flu Vaccine Sales Estimates and Forecasts 2024-2034
2.2 Global Animal Flu Vaccine Revenue by Region
2.2.1 Global Animal Flu Vaccine Revenue by Region: 2024 VS 2022 VS 2034
2.2.2 Global Animal Flu Vaccine Revenue by Region (2024-2024)
2.2.3 Global Animal Flu Vaccine Revenue by Region (2024-2034)
2.2.4 Global Animal Flu Vaccine Revenue Market Share by Region (2024-2034)
2.3 Global Animal Flu Vaccine Sales Estimates and Forecasts 2024-2034
2.4 Global Animal Flu Vaccine Sales by Region
2.4.1 Global Animal Flu Vaccine Sales by Region: 2024 VS 2022 VS 2034
2.4.2 Global Animal Flu Vaccine Sales by Region (2024-2024)
2.4.3 Global Animal Flu Vaccine Sales by Region (2024-2034)
2.4.4 Global Animal Flu Vaccine Sales Market Share by Region (2024-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Animal Flu Vaccine Sales by Manufacturers
3.1.1 Global Animal Flu Vaccine Sales by Manufacturers (2024-2024)
3.1.2 Global Animal Flu Vaccine Sales Market Share by Manufacturers (2024-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Animal Flu Vaccine in 2022
3.2 Global Animal Flu Vaccine Revenue by Manufacturers
3.2.1 Global Animal Flu Vaccine Revenue by Manufacturers (2024-2024)
3.2.2 Global Animal Flu Vaccine Revenue Market Share by Manufacturers (2024-2024)
3.2.3 Global Top 10 and Top 5 Companies by Animal Flu Vaccine Revenue in 2022
3.3 Global Key Players of Animal Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Animal Flu Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Animal Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Animal Flu Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Animal Flu Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Animal Flu Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Animal Flu Vaccine Sales by Type
4.1.1 Global Animal Flu Vaccine Historical Sales by Type (2024-2024)
4.1.2 Global Animal Flu Vaccine Forecasted Sales by Type (2024-2034)
4.1.3 Global Animal Flu Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Animal Flu Vaccine Revenue by Type
4.2.1 Global Animal Flu Vaccine Historical Revenue by Type (2024-2024)
4.2.2 Global Animal Flu Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Animal Flu Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Animal Flu Vaccine Price by Type
4.3.1 Global Animal Flu Vaccine Price by Type (2024-2024)
4.3.2 Global Animal Flu Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Animal Flu Vaccine Sales by Application
5.1.1 Global Animal Flu Vaccine Historical Sales by Application (2024-2024)
5.1.2 Global Animal Flu Vaccine Forecasted Sales by Application (2024-2034)
5.1.3 Global Animal Flu Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Animal Flu Vaccine Revenue by Application
5.2.1 Global Animal Flu Vaccine Historical Revenue by Application (2024-2024)
5.2.2 Global Animal Flu Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Animal Flu Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Animal Flu Vaccine Price by Application
5.3.1 Global Animal Flu Vaccine Price by Application (2024-2024)
5.3.2 Global Animal Flu Vaccine Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Animal Flu Vaccine Market Size by Type
6.1.1 US & Canada Animal Flu Vaccine Sales by Type (2024-2034)
6.1.2 US & Canada Animal Flu Vaccine Revenue by Type (2024-2034)
6.2 US & Canada Animal Flu Vaccine Market Size by Application
6.2.1 US & Canada Animal Flu Vaccine Sales by Application (2024-2034)
6.2.2 US & Canada Animal Flu Vaccine Revenue by Application (2024-2034)
6.3 US & Canada Animal Flu Vaccine Market Size by Country
6.3.1 US & Canada Animal Flu Vaccine Revenue by Country: 2024 VS 2022 VS 2034
6.3.2 US & Canada Animal Flu Vaccine Sales by Country (2024-2034)
6.3.3 US & Canada Animal Flu Vaccine Revenue by Country (2024-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Animal Flu Vaccine Market Size by Type
7.1.1 Europe Animal Flu Vaccine Sales by Type (2024-2034)
7.1.2 Europe Animal Flu Vaccine Revenue by Type (2024-2034)
7.2 Europe Animal Flu Vaccine Market Size by Application
7.2.1 Europe Animal Flu Vaccine Sales by Application (2024-2034)
7.2.2 Europe Animal Flu Vaccine Revenue by Application (2024-2034)
7.3 Europe Animal Flu Vaccine Market Size by Country
7.3.1 Europe Animal Flu Vaccine Revenue by Country: 2024 VS 2022 VS 2034
7.3.2 Europe Animal Flu Vaccine Sales by Country (2024-2034)
7.3.3 Europe Animal Flu Vaccine Revenue by Country (2024-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Animal Flu Vaccine Market Size
8.1.1 China Animal Flu Vaccine Sales (2024-2034)
8.1.2 China Animal Flu Vaccine Revenue (2024-2034)
8.2 China Animal Flu Vaccine Market Size by Application
8.2.1 China Animal Flu Vaccine Sales by Application (2024-2034)
8.2.2 China Animal Flu Vaccine Revenue by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Animal Flu Vaccine Market Size by Type
9.1.1 Asia Animal Flu Vaccine Sales by Type (2024-2034)
9.1.2 Asia Animal Flu Vaccine Revenue by Type (2024-2034)
9.2 Asia Animal Flu Vaccine Market Size by Application
9.2.1 Asia Animal Flu Vaccine Sales by Application (2024-2034)
9.2.2 Asia Animal Flu Vaccine Revenue by Application (2024-2034)
9.3 Asia Animal Flu Vaccine Sales by Region
9.3.1 Asia Animal Flu Vaccine Revenue by Region: 2024 VS 2022 VS 2034
9.3.2 Asia Animal Flu Vaccine Revenue by Region (2024-2034)
9.3.3 Asia Animal Flu Vaccine Sales by Region (2024-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Animal Flu Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Animal Flu Vaccine Sales by Type (2024-2034)
10.1.2 Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Type (2024-2034)
10.2 Middle East, Africa and Latin America Animal Flu Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Animal Flu Vaccine Sales by Application (2024-2034)
10.2.2 Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Application (2024-2034)
10.3 Middle East, Africa and Latin America Animal Flu Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Country: 2024 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Country (2024-2034)
10.3.3 Middle East, Africa and Latin America Animal Flu Vaccine Sales by Country (2024-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Zoetis US
11.1.1 Zoetis US Company Information
11.1.2 Zoetis US Overview
11.1.3 Zoetis US Animal Flu Vaccine Sales, Price, Revenue and Gross Margin (2024-2024)
11.1.4 Zoetis US Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis US Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Information
11.2.2 Merck Animal Health Overview
11.2.3 Merck Animal Health Animal Flu Vaccine Sales, Price, Revenue and Gross Margin (2024-2024)
11.2.4 Merck Animal Health Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Animal Health Recent Developments
11.3 Gamma Vaccines Pty Ltd
11.3.1 Gamma Vaccines Pty Ltd Company Information
11.3.2 Gamma Vaccines Pty Ltd Overview
11.3.3 Gamma Vaccines Pty Ltd Animal Flu Vaccine Sales, Price, Revenue and Gross Margin (2024-2024)
11.3.4 Gamma Vaccines Pty Ltd Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gamma Vaccines Pty Ltd Recent Developments
11.4 Ceva Animal Health
11.4.1 Ceva Animal Health Company Information
11.4.2 Ceva Animal Health Overview
11.4.3 Ceva Animal Health Animal Flu Vaccine Sales, Price, Revenue and Gross Margin (2024-2024)
11.4.4 Ceva Animal Health Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Animal Health Recent Developments
11.5 Boehringher Ingelheim
11.5.1 Boehringher Ingelheim Company Information
11.5.2 Boehringher Ingelheim Overview
11.5.3 Boehringher Ingelheim Animal Flu Vaccine Sales, Price, Revenue and Gross Margin (2024-2024)
11.5.4 Boehringher Ingelheim Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boehringher Ingelheim Recent Developments
11.6 Novartis China
11.6.1 Novartis China Company Information
11.6.2 Novartis China Overview
11.6.3 Novartis China Animal Flu Vaccine Sales, Price, Revenue and Gross Margin (2024-2024)
11.6.4 Novartis China Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis China Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Animal Flu Vaccine Industry Chain Analysis
12.2 Animal Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal Flu Vaccine Production Mode & Process
12.4 Animal Flu Vaccine Sales and Marketing
12.4.1 Animal Flu Vaccine Sales Channels
12.4.2 Animal Flu Vaccine Distributors
12.5 Animal Flu Vaccine Customers
13 Market Dynamics
13.1 Animal Flu Vaccine Industry Trends
13.2 Animal Flu Vaccine Market Drivers
13.3 Animal Flu Vaccine Market Challenges
13.4 Animal Flu Vaccine Market Restraints
14 Key Findings in The Global Animal Flu Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Flu Vaccine Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Monovalent
Table 3. Major Manufacturers of Bivalent
Table 4. Major Manufacturers of Others
Table 5. Global Animal Flu Vaccine Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Animal Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Animal Flu Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 8. Global Animal Flu Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Animal Flu Vaccine Revenue Market Share by Region (2024-2024)
Table 10. Global Animal Flu Vaccine Revenue Market Share by Region (2024-2034)
Table 11. Global Animal Flu Vaccine Sales Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 12. Global Animal Flu Vaccine Sales by Region (2024-2024) & (K Units)
Table 13. Global Animal Flu Vaccine Sales by Region (2024-2034) & (K Units)
Table 14. Global Animal Flu Vaccine Sales Market Share by Region (2024-2024)
Table 15. Global Animal Flu Vaccine Sales Market Share by Region (2024-2034)
Table 16. Global Animal Flu Vaccine Sales by Manufacturers (2024-2024) & (K Units)
Table 17. Global Animal Flu Vaccine Sales Share by Manufacturers (2024-2024)
Table 18. Global Animal Flu Vaccine Revenue by Manufacturers (2024-2024) & (US$ Million)
Table 19. Global Animal Flu Vaccine Revenue Share by Manufacturers (2024-2024)
Table 20. Global Key Players of Animal Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Animal Flu Vaccine Price by Manufacturers 2024-2024 (US$/Unit)
Table 22. Global Animal Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Animal Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Flu Vaccine as of 2022)
Table 24. Global Key Manufacturers of Animal Flu Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Animal Flu Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Animal Flu Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Animal Flu Vaccine Sales by Type (2024-2024) & (K Units)
Table 29. Global Animal Flu Vaccine Sales by Type (2024-2034) & (K Units)
Table 30. Global Animal Flu Vaccine Sales Share by Type (2024-2024)
Table 31. Global Animal Flu Vaccine Sales Share by Type (2024-2034)
Table 32. Global Animal Flu Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 33. Global Animal Flu Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Animal Flu Vaccine Revenue Share by Type (2024-2024)
Table 35. Global Animal Flu Vaccine Revenue Share by Type (2024-2034)
Table 36. Animal Flu Vaccine Price by Type (2024-2024) & (US$/Unit)
Table 37. Global Animal Flu Vaccine Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Animal Flu Vaccine Sales by Application (2024-2024) & (K Units)
Table 39. Global Animal Flu Vaccine Sales by Application (2024-2034) & (K Units)
Table 40. Global Animal Flu Vaccine Sales Share by Application (2024-2024)
Table 41. Global Animal Flu Vaccine Sales Share by Application (2024-2034)
Table 42. Global Animal Flu Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 43. Global Animal Flu Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Animal Flu Vaccine Revenue Share by Application (2024-2024)
Table 45. Global Animal Flu Vaccine Revenue Share by Application (2024-2034)
Table 46. Animal Flu Vaccine Price by Application (2024-2024) & (US$/Unit)
Table 47. Global Animal Flu Vaccine Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. US & Canada Animal Flu Vaccine Sales by Type (2024-2024) & (K Units)
Table 49. US & Canada Animal Flu Vaccine Sales by Type (2024-2034) & (K Units)
Table 50. US & Canada Animal Flu Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 51. US & Canada Animal Flu Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 52. US & Canada Animal Flu Vaccine Sales by Application (2024-2024) & (K Units)
Table 53. US & Canada Animal Flu Vaccine Sales by Application (2024-2034) & (K Units)
Table 54. US & Canada Animal Flu Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 55. US & Canada Animal Flu Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 56. US & Canada Animal Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 57. US & Canada Animal Flu Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 58. US & Canada Animal Flu Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 59. US & Canada Animal Flu Vaccine Sales by Country (2024-2024) & (K Units)
Table 60. US & Canada Animal Flu Vaccine Sales by Country (2024-2034) & (K Units)
Table 61. Europe Animal Flu Vaccine Sales by Type (2024-2024) & (K Units)
Table 62. Europe Animal Flu Vaccine Sales by Type (2024-2034) & (K Units)
Table 63. Europe Animal Flu Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 64. Europe Animal Flu Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 65. Europe Animal Flu Vaccine Sales by Application (2024-2024) & (K Units)
Table 66. Europe Animal Flu Vaccine Sales by Application (2024-2034) & (K Units)
Table 67. Europe Animal Flu Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 68. Europe Animal Flu Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 69. Europe Animal Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 70. Europe Animal Flu Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 71. Europe Animal Flu Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 72. Europe Animal Flu Vaccine Sales by Country (2024-2024) & (K Units)
Table 73. Europe Animal Flu Vaccine Sales by Country (2024-2034) & (K Units)
Table 74. China Animal Flu Vaccine Sales by Type (2024-2024) & (K Units)
Table 75. China Animal Flu Vaccine Sales by Type (2024-2034) & (K Units)
Table 76. China Animal Flu Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 77. China Animal Flu Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 78. China Animal Flu Vaccine Sales by Application (2024-2024) & (K Units)
Table 79. China Animal Flu Vaccine Sales by Application (2024-2034) & (K Units)
Table 80. China Animal Flu Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 81. China Animal Flu Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 82. Asia Animal Flu Vaccine Sales by Type (2024-2024) & (K Units)
Table 83. Asia Animal Flu Vaccine Sales by Type (2024-2034) & (K Units)
Table 84. Asia Animal Flu Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 85. Asia Animal Flu Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 86. Asia Animal Flu Vaccine Sales by Application (2024-2024) & (K Units)
Table 87. Asia Animal Flu Vaccine Sales by Application (2024-2034) & (K Units)
Table 88. Asia Animal Flu Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 89. Asia Animal Flu Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 90. Asia Animal Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 91. Asia Animal Flu Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 92. Asia Animal Flu Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 93. Asia Animal Flu Vaccine Sales by Region (2024-2024) & (K Units)
Table 94. Asia Animal Flu Vaccine Sales by Region (2024-2034) & (K Units)
Table 95. Middle East, Africa and Latin America Animal Flu Vaccine Sales by Type (2024-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Animal Flu Vaccine Sales by Type (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 99. Middle East, Africa and Latin America Animal Flu Vaccine Sales by Application (2024-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Animal Flu Vaccine Sales by Application (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America Animal Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 104. Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Animal Flu Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 106. Middle East, Africa and Latin America Animal Flu Vaccine Sales by Country (2024-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Animal Flu Vaccine Sales by Country (2024-2034) & (K Units)
Table 108. Zoetis US Company Information
Table 109. Zoetis US Description and Major Businesses
Table 110. Zoetis US Animal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Zoetis US Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Zoetis US Recent Developments
Table 113. Merck Animal Health Company Information
Table 114. Merck Animal Health Description and Major Businesses
Table 115. Merck Animal Health Animal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Merck Animal Health Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Merck Animal Health Recent Developments
Table 118. Gamma Vaccines Pty Ltd Company Information
Table 119. Gamma Vaccines Pty Ltd Description and Major Businesses
Table 120. Gamma Vaccines Pty Ltd Animal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Gamma Vaccines Pty Ltd Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Gamma Vaccines Pty Ltd Recent Developments
Table 123. Ceva Animal Health Company Information
Table 124. Ceva Animal Health Description and Major Businesses
Table 125. Ceva Animal Health Animal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Ceva Animal Health Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Ceva Animal Health Recent Developments
Table 128. Boehringher Ingelheim Company Information
Table 129. Boehringher Ingelheim Description and Major Businesses
Table 130. Boehringher Ingelheim Animal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Boehringher Ingelheim Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Boehringher Ingelheim Recent Developments
Table 133. Novartis China Company Information
Table 134. Novartis China Description and Major Businesses
Table 135. Novartis China Animal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Novartis China Animal Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Novartis China Recent Developments
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Animal Flu Vaccine Distributors List
Table 141. Animal Flu Vaccine Customers List
Table 142. Animal Flu Vaccine Market Trends
Table 143. Animal Flu Vaccine Market Drivers
Table 144. Animal Flu Vaccine Market Challenges
Table 145. Animal Flu Vaccine Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Flu Vaccine Product Picture
Figure 2. Global Animal Flu Vaccine Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Animal Flu Vaccine Market Share by Type in 2022 & 2034
Figure 4. Monovalent Product Picture
Figure 5. Bivalent Product Picture
Figure 6. Others Product Picture
Figure 7. Global Animal Flu Vaccine Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Animal Flu Vaccine Market Share by Application in 2022 & 2034
Figure 9. Birds
Figure 10. Dog
Figure 11. Pig
Figure 12. Others
Figure 13. Animal Flu Vaccine Report Years Considered
Figure 14. Global Animal Flu Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Animal Flu Vaccine Revenue 2024-2034 (US$ Million)
Figure 16. Global Animal Flu Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Animal Flu Vaccine Revenue Market Share by Region (2024-2034)
Figure 18. Global Animal Flu Vaccine Sales 2024-2034 ((K Units)
Figure 19. Global Animal Flu Vaccine Sales Market Share by Region (2024-2034)
Figure 20. US & Canada Animal Flu Vaccine Sales YoY (2024-2034) & (K Units)
Figure 21. US & Canada Animal Flu Vaccine Revenue YoY (2024-2034) & (US$ Million)
Figure 22. Europe Animal Flu Vaccine Sales YoY (2024-2034) & (K Units)
Figure 23. Europe Animal Flu Vaccine Revenue YoY (2024-2034) & (US$ Million)
Figure 24. China Animal Flu Vaccine Sales YoY (2024-2034) & (K Units)
Figure 25. China Animal Flu Vaccine Revenue YoY (2024-2034) & (US$ Million)
Figure 26. Asia (excluding China) Animal Flu Vaccine Sales YoY (2024-2034) & (K Units)
Figure 27. Asia (excluding China) Animal Flu Vaccine Revenue YoY (2024-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Animal Flu Vaccine Sales YoY (2024-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Animal Flu Vaccine Revenue YoY (2024-2034) & (US$ Million)
Figure 30. The Animal Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Animal Flu Vaccine in the World: Market Share by Animal Flu Vaccine Revenue in 2022
Figure 32. Global Animal Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 33. Global Animal Flu Vaccine Sales Market Share by Type (2024-2034)
Figure 34. Global Animal Flu Vaccine Revenue Market Share by Type (2024-2034)
Figure 35. Global Animal Flu Vaccine Sales Market Share by Application (2024-2034)
Figure 36. Global Animal Flu Vaccine Revenue Market Share by Application (2024-2034)
Figure 37. US & Canada Animal Flu Vaccine Sales Market Share by Type (2024-2034)
Figure 38. US & Canada Animal Flu Vaccine Revenue Market Share by Type (2024-2034)
Figure 39. US & Canada Animal Flu Vaccine Sales Market Share by Application (2024-2034)
Figure 40. US & Canada Animal Flu Vaccine Revenue Market Share by Application (2024-2034)
Figure 41. US & Canada Animal Flu Vaccine Revenue Share by Country (2024-2034)
Figure 42. US & Canada Animal Flu Vaccine Sales Share by Country (2024-2034)
Figure 43. U.S. Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 44. Canada Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 45. Europe Animal Flu Vaccine Sales Market Share by Type (2024-2034)
Figure 46. Europe Animal Flu Vaccine Revenue Market Share by Type (2024-2034)
Figure 47. Europe Animal Flu Vaccine Sales Market Share by Application (2024-2034)
Figure 48. Europe Animal Flu Vaccine Revenue Market Share by Application (2024-2034)
Figure 49. Europe Animal Flu Vaccine Revenue Share by Country (2024-2034)
Figure 50. Europe Animal Flu Vaccine Sales Share by Country (2024-2034)
Figure 51. Germany Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 52. France Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 53. U.K. Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 54. Italy Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 55. Russia Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 56. China Animal Flu Vaccine Sales Market Share by Type (2024-2034)
Figure 57. China Animal Flu Vaccine Revenue Market Share by Type (2024-2034)
Figure 58. China Animal Flu Vaccine Sales Market Share by Application (2024-2034)
Figure 59. China Animal Flu Vaccine Revenue Market Share by Application (2024-2034)
Figure 60. Asia Animal Flu Vaccine Sales Market Share by Type (2024-2034)
Figure 61. Asia Animal Flu Vaccine Revenue Market Share by Type (2024-2034)
Figure 62. Asia Animal Flu Vaccine Sales Market Share by Application (2024-2034)
Figure 63. Asia Animal Flu Vaccine Revenue Market Share by Application (2024-2034)
Figure 64. Asia Animal Flu Vaccine Revenue Share by Region (2024-2034)
Figure 65. Asia Animal Flu Vaccine Sales Share by Region (2024-2034)
Figure 66. Japan Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 67. South Korea Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 68. China Taiwan Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 69. Southeast Asia Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 70. India Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Animal Flu Vaccine Sales Market Share by Type (2024-2034)
Figure 72. Middle East, Africa and Latin America Animal Flu Vaccine Revenue Market Share by Type (2024-2034)
Figure 73. Middle East, Africa and Latin America Animal Flu Vaccine Sales Market Share by Application (2024-2034)
Figure 74. Middle East, Africa and Latin America Animal Flu Vaccine Revenue Market Share by Application (2024-2034)
Figure 75. Middle East, Africa and Latin America Animal Flu Vaccine Revenue Share by Country (2024-2034)
Figure 76. Middle East, Africa and Latin America Animal Flu Vaccine Sales Share by Country (2024-2034)
Figure 77. Brazil Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 78. Mexico Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 79. Turkey Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 80. Israel Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 81. GCC Countries Animal Flu Vaccine Revenue (2024-2034) & (US$ Million)
Figure 82. Animal Flu Vaccine Value Chain
Figure 83. Animal Flu Vaccine Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed